Clinical Trials Directory

Trials / Completed

CompletedNCT00664963

YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study

YUKON-drug-eluting Stent Below The Knee - Prospective Randomized Double-blind Multicenter Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Herz-Zentrums Bad Krozingen · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effectiveness of the treatment with balloon-expandable YUKON-BTX-Sirolimus-eluting stent over the treatment with YUKON-BTX uncoated stent in patients with ischemic infrapopliteal arterial disease.

Detailed description

Based on the fact that drug eluting stents have been proven to reduce the restenosis rate in the coronary arteries, we assume that YUKON-BTX-Sirolimus-eluting stent has a superior restenosis rate compared to treatment with uncoated stent in the below-the-knee arteries consecutively. The purpose of this study is to compare the restenosis rate of the treatment with balloon-expandable YUKON-BTX-Sirolimus-eluting stent over the treatment with YUKON-BTX uncoated stent in patients with ischemic infrapopliteal arterial disease. Randomisation will be performed by extremity, that may lead to varying treatments within one patient during the study.

Conditions

Interventions

TypeNameDescription
DEVICEImplantation of YUKON Sirolimus-eluting StentImplantation of YUKON Sirolimus-eluting Stent
DEVICEImplantation of YUKON Stent (uncoated)Implantation of YUKON Stent (uncoated)

Timeline

Start date
2006-04-01
Primary completion
2010-03-01
Completion
2010-04-01
First posted
2008-04-23
Last updated
2014-12-17

Locations

3 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00664963. Inclusion in this directory is not an endorsement.